11827684

Source:http://linkedlifedata.com/resource/pubmed/id/11827684

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019010, umls-concept:C0077932, umls-concept:C0086418, umls-concept:C0205276, umls-concept:C0205373, umls-concept:C0683150
pubmed:issue	2
pubmed:dateCreated	2002-2-5
pubmed:abstractText	Human urotensin II (hUII) is an endocrine hormone that acts as a potent arterial vasoconstrictor in both in vitro and in vivo studies in animals. We examined, for the first time, the local and systemic hemodynamic response to hUII in man in vivo.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0077427
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Epoprostenol, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Donors, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/SNP-1 protein, synthetic, http://linkedlifedata.com/resource/pubmed/chemical/Thromboxanes, http://linkedlifedata.com/resource/pubmed/chemical/Urotensins, http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents, http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine, http://linkedlifedata.com/resource/pubmed/chemical/urotensin II
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0008-6363
pubmed:author	pubmed-author:AffolterJonathan TJT, pubmed-author:BalmentRichard JRJ, pubmed-author:BoydJudithJ, pubmed-author:PellegriniM PaolaMP, pubmed-author:WebbDavid JDJ, pubmed-author:WilkinsonIan BIB, pubmed-author:WinterMatthew JMJ, pubmed-author:de HaasSanne LSL
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	53
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	341-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11827684-Adult, pubmed-meshheading:11827684-Analysis of Variance, pubmed-meshheading:11827684-Aspirin, pubmed-meshheading:11827684-Blood Pressure, pubmed-meshheading:11827684-Carrier Proteins, pubmed-meshheading:11827684-Enzyme Inhibitors, pubmed-meshheading:11827684-Epoprostenol, pubmed-meshheading:11827684-Forearm, pubmed-meshheading:11827684-Hand, pubmed-meshheading:11827684-Humans, pubmed-meshheading:11827684-Infusions, Intra-Arterial, pubmed-meshheading:11827684-Male, pubmed-meshheading:11827684-Middle Aged, pubmed-meshheading:11827684-Nitric Oxide Donors, pubmed-meshheading:11827684-Nitric Oxide Synthase, pubmed-meshheading:11827684-Peptides, pubmed-meshheading:11827684-Pilot Projects, pubmed-meshheading:11827684-Plethysmography, pubmed-meshheading:11827684-Regional Blood Flow, pubmed-meshheading:11827684-Thromboxanes, pubmed-meshheading:11827684-Urotensins, pubmed-meshheading:11827684-Vasoconstrictor Agents, pubmed-meshheading:11827684-Veins, pubmed-meshheading:11827684-omega-N-Methylarginine
pubmed:year	2002
pubmed:articleTitle	High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.
pubmed:affiliation	Clinical Pharmacology Unit, Department of Medical Sciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2LH, Scotland, UK.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial, Research Support, Non-U.S. Gov't